Literature DB >> 22695395

Developmental reprogramming of cancer susceptibility.

Cheryl Lyn Walker1, Shuk-mei Ho.   

Abstract

Gene-environment interactions have been traditionally understood to promote the acquisition of mutations that drive multistage carcinogenesis, and, in the case of inherited defects in tumour suppressor genes, additional mutations are required for cancer development. However, the developmental origins of health and disease (DOHAD) hypothesis provides an alternative model whereby environmental exposures during development increase susceptibility to cancer in adulthood, not by inducing genetic mutations, but by reprogramming the epigenome. We hypothesize that this epigenetic reprogramming functions as a new type of gene-environment interaction by which environmental exposures target the epigenome to increase cancer susceptibility.

Entities:  

Mesh:

Year:  2012        PMID: 22695395      PMCID: PMC3820510          DOI: 10.1038/nrc3220

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  79 in total

Review 1.  Epigenetics and environment: a complex relationship.

Authors:  Oscar Aguilera; Agustín F Fernández; Alberto Muñoz; Mario F Fraga
Journal:  J Appl Physiol (1985)       Date:  2010-04-08

2.  Prenatal diethylstilbestrol exposure and risk of breast cancer.

Authors:  Julie R Palmer; Lauren A Wise; Elizabeth E Hatch; Rebecca Troisi; Linda Titus-Ernstoff; William Strohsnitter; Raymond Kaufman; Arthur L Herbst; Kenneth L Noller; Marianne Hyer; Robert N Hoover
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-08       Impact factor: 4.254

3.  Adenocarcinoma of the rete testis. Diethylstilbestrol-induced lesions of the mouse rete testis.

Authors:  R R Newbold; B C Bullock; J A McLachlan
Journal:  Am J Pathol       Date:  1986-12       Impact factor: 4.307

4.  Bisphenol-A exposure in utero leads to epigenetic alterations in the developmental programming of uterine estrogen response.

Authors:  Jason G Bromer; Yuping Zhou; Melissa B Taylor; Leo Doherty; Hugh S Taylor
Journal:  FASEB J       Date:  2010-02-24       Impact factor: 5.191

Review 5.  Inherited mutations in breast cancer genes--risk and response.

Authors:  Andrew Y Shuen; William D Foulkes
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-04-05       Impact factor: 2.673

6.  Birth size and subsequent risk for prostate cancer: a prospective population-based study in Norway.

Authors:  Tom I L Nilsen; Pål R Romundstad; Rebecca Troisi; Lars J Vatten
Journal:  Int J Cancer       Date:  2005-03-01       Impact factor: 7.396

7.  PRMT5-mediated methylation of histone H4R3 recruits DNMT3A, coupling histone and DNA methylation in gene silencing.

Authors:  Quan Zhao; Gerhard Rank; Yuen T Tan; Haitao Li; Robert L Moritz; Richard J Simpson; Loretta Cerruti; David J Curtis; Dinshaw J Patel; C David Allis; John M Cunningham; Stephen M Jane
Journal:  Nat Struct Mol Biol       Date:  2009-02-22       Impact factor: 15.369

8.  Birth weight as a risk factor for childhood leukemia: a meta-analysis of 18 epidemiologic studies.

Authors:  Lisa Lyngsie Hjalgrim; Tine Westergaard; Klaus Rostgaard; Kjeld Schmiegelow; Mads Melbye; Henrik Hjalgrim; Eric A Engels
Journal:  Am J Epidemiol       Date:  2003-10-15       Impact factor: 4.897

9.  Neonatal diethylstilbestrol exposure induces persistent elevation of c-fos expression and hypomethylation in its exon-4 in mouse uterus.

Authors:  Shuanfang Li; Roberta Hansman; Retha Newbold; Barbara Davis; John A McLachlan; J Carl Barrett
Journal:  Mol Carcinog       Date:  2003-10       Impact factor: 4.784

Review 10.  Breast development, hormones and cancer.

Authors:  Jose Russo; Irma H Russo
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

View more
  66 in total

1.  Cluster of Differentiation 44 (CD44) Gene Variants: A Putative Cancer Stem Cell Marker in Risk Prediction of Bladder Cancer in North Indian Population.

Authors:  Archana Verma; Rakesh Kapoor; Rama Devi Mittal
Journal:  Indian J Clin Biochem       Date:  2016-05-21

Review 2.  Phosphorylation of epigenetic "readers, writers and erasers": Implications for developmental reprogramming and the epigenetic basis for health and disease.

Authors:  Lindsey S Treviño; Quan Wang; Cheryl L Walker
Journal:  Prog Biophys Mol Biol       Date:  2015-04-02       Impact factor: 3.667

Review 3.  Developmental origins of health and disease: a paradigm for understanding disease cause and prevention.

Authors:  Jerrold J Heindel; Laura N Vandenberg
Journal:  Curr Opin Pediatr       Date:  2015-04       Impact factor: 2.856

Review 4.  Analysing and interpreting DNA methylation data.

Authors:  Christoph Bock
Journal:  Nat Rev Genet       Date:  2012-10       Impact factor: 53.242

5.  Molecular pathways: environmental estrogens activate nongenomic signaling to developmentally reprogram the epigenome.

Authors:  Rebecca Lee Yean Wong; Cheryl Lyn Walker
Journal:  Clin Cancer Res       Date:  2013-04-02       Impact factor: 12.531

6.  The Epidemics of Obesity and Cancer: No simple remedy.

Authors:  Moza Al-Kalbani; Ikram A Burney
Journal:  Sultan Qaboos Univ Med J       Date:  2014-07-24

7.  Developmental Environmental Exposure Alters the Epigenetic Features of Myometrial Stem Cells.

Authors:  Qiwei Yang; Ayman Al-Hendy
Journal:  Gynecol Obstet Res       Date:  2016-12-01

8.  Developmental exposure to endocrine disrupting chemicals alters the epigenome: Identification of reprogrammed targets.

Authors:  Lauren Prusinski; Ayman Al-Hendy; Qiwei Yang
Journal:  Gynecol Obstet Res       Date:  2016-05-03

Review 9.  Assessing health risks from multiple environmental stressors: Moving from G×E to I×E.

Authors:  Cliona M McHale; Gwendolyn Osborne; Rachel Morello-Frosch; Andrew G Salmon; Martha S Sandy; Gina Solomon; Luoping Zhang; Martyn T Smith; Lauren Zeise
Journal:  Mutat Res Rev Mutat Res       Date:  2017-11-24       Impact factor: 5.657

Review 10.  Emerging roles for chromatin as a signal integration and storage platform.

Authors:  Aimee I Badeaux; Yang Shi
Journal:  Nat Rev Mol Cell Biol       Date:  2013-04       Impact factor: 94.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.